Compare QQQX & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | QQQX | OMCL |
|---|---|---|
| Founded | 2007 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Computer Manufacturing |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.5B |
| IPO Year | N/A | 2000 |
| Metric | QQQX | OMCL |
|---|---|---|
| Price | $29.53 | $38.23 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $53.67 |
| AVG Volume (30 Days) | 145.9K | ★ 374.9K |
| Earning Date | 01-01-0001 | 04-28-2026 |
| Dividend Yield | ★ 7.03% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.04 |
| Revenue | N/A | ★ $787,309,000.00 |
| Revenue This Year | N/A | $6.77 |
| Revenue Next Year | N/A | $5.22 |
| P/E Ratio | ★ N/A | $937.50 |
| Revenue Growth | N/A | ★ 9.93 |
| 52 Week Low | $21.64 | $22.66 |
| 52 Week High | $29.59 | $51.84 |
| Indicator | QQQX | OMCL |
|---|---|---|
| Relative Strength Index (RSI) | 70.06 | 60.50 |
| Support Level | $27.08 | $32.20 |
| Resistance Level | N/A | $42.60 |
| Average True Range (ATR) | 0.48 | 1.31 |
| MACD | 0.27 | 0.71 |
| Stochastic Oscillator | 96.43 | 88.55 |
Nuveen NASDAQ 100 Dynamic Overwrite Fund is a closed-end management investment company. Its investment objective is to seek attractive total return with less volatility than the S&P 500 Index. Under normal circumstances, the Fund will invest at least 80% of its Assets (as defined below) in a diversified equity portfolio made up of securities comprising the S&P 500 Index (or securities that have economic characteristics that are similar to those securities comprising the S&P 500 Index) that seeks to substantially replicate price movements of the S&P 500 Index and is designed to support the Fund's option strategy.
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.